||Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2009;58(RR-2):1–25.
||Centers for Disease Control and Prevention (CDC). Rotavirus. In: Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Washington, DC: Public Health Foundation; 2015:311–324. http://www.cdc.gov/vaccines/pubs/
pinkbook/index.html. Accessed June 27, 2018.
||Payne DC, Parashar UD. Rotavirus. In: Roush SW, Baldy LM, eds. Manual for the Surveillance of Vaccine-Preventable Diseases. Atlanta, GA: Centers for Disease Control and Prevention (CDC) and Department of Health and Human Services; 2008:1–17. https://www.cdc.gov/vaccines/pubs/surv-manual/index.html. Accessed June 27, 2018.
||Mayo Clinic. Mayo Clinic Web site. Rotavirus. https://www.mayoclinic.org/diseases-conditions/rotavirus/symptoms-causes/syc-20351300?p=1. Accessed June 27, 2018.
||Mayo Clinic. Mayo Clinic Web site. Dehydration. https://www.mayoclinic.org/diseases-conditions/dehydration/symptoms-causes/syc-20354086?p=1. Accessed June 27, 2018.
||Centers for Disease Control and Prevention (CDC). CDC Web site. Rotavirus symptoms. https://www.cdc.gov/rotavirus/about/symptoms.html. Last updated: April 23, 2018. Accessed June 27, 2018.
||National Foundation for Infectious Diseases (NFID). Frequently asked questions about rotavirus. http://www.nfid.org/idinfo/rotavirus/faqs.html. Accessed June 27, 2018.
||Dormitzer PR. Rotaviruses. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Vol 2. 8th ed. Philadelphia, PA: Elsevier Saunders; 2015:1854–1864.
||Ansari SA, Sattar SA, Springthorpe VS, et al. Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces. J Clin Microbiol. 1988;26(8):1513–1518.
||Dóró R, László B, Martella V, et al. Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure? Infect Genet Evol. 2014;28:446–461.
||Gentsch JR, Laird AR, Bielfelt B, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis. 2005;192(suppl 1):S146–S159.
||Matthijnssens J, Van Ranst M. Genotype constellation and evolution of group A rotaviruses infecting humans. Curr Opin Virol. 2012;2(4):426–433.
||Dennis AF, McDonald SM, Payne DC, et al. Molecular epidemiology of contemporary G2P human rotaviruses cocirculating in a single U.S. community: footprints of a globally transitioning genotype. J Virol. 2014;88(7):3789–3801.
||Velázquez FR, Matson DO, Calva JJ, et al. Rotavirus infection in infants as protection against
subsequent infections. N Engl J Med. 1996;335(14):1022–1028.